Analysis of EPCAM protein expression in diagnostics of Lynch syndrome
Purpose: Lynch syndrome is an inherited tumor predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes, mainly MLH1 and MSH2. Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel m...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Journal of clinical oncology
Year: 2011, Jahrgang: 29, Heft: 2, Pages: 223-227 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2010.32.0820 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2010.32.0820 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2010.32.0820 
|
| Verfasserangaben: | Matthias Kloor, Anita Y. Voigt, Hans K. Schackert, Peter Schirmacher, Magnus von Knebel Doeberitz, and Hendrik Bläker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 181693030X | ||
| 003 | DE-627 | ||
| 005 | 20230710114621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220919s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2010.32.0820 |2 doi | |
| 035 | |a (DE-627)181693030X | ||
| 035 | |a (DE-599)KXP181693030X | ||
| 035 | |a (OCoLC)1389788325 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kloor, Matthias |d 1972- |e VerfasserIn |0 (DE-588)124552803 |0 (DE-627)363416609 |0 (DE-576)294228616 |4 aut | |
| 245 | 1 | 0 | |a Analysis of EPCAM protein expression in diagnostics of Lynch syndrome |c Matthias Kloor, Anita Y. Voigt, Hans K. Schackert, Peter Schirmacher, Magnus von Knebel Doeberitz, and Hendrik Bläker |
| 264 | 1 | |c 2011 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online ahead of print at www.jco.org on November 29, 2010 | ||
| 500 | |a Gesehen am 19.09.2022 | ||
| 520 | |a Purpose: Lynch syndrome is an inherited tumor predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes, mainly MLH1 and MSH2. Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele. Immunohistochemical analysis of MMR protein expression is a hallmark of Lynch syndrome diagnostics, but it cannot distinguish between EPCAM deletion carriers and MSH2 mutation carriers. We hypothesized that EPCAM protein expression might be altered in tumors from patients with a germline EPCAM deletion. - Patients and Methods: Immunohistochemistry was used to assess EPCAM expression in Lynch syndrome-associated MSH2-negative tumors (n = 26). Multiplex ligation-dependent probe amplification (MLPA) analysis was performed to detect germline deletions of the EPCAM and MSH2 gene loci. - Results: In four MSH2-negative tumors, a concomitant lack of EPCAM expression was detected. MLPA analysis revealed heterozygous EPCAM deletions in all patients with EPCAM-negative tumors. In contrast, EPCAM expression was positive in all cancers from patients with germline alterations affecting MSH2 but not EPCAM. Two EPCAM deletions were detected in patients with an EPCAM-positive tumor. - Conclusion: These results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions. EPCAM immunohistochemistry therefore represents a promising novel tool for the identification of Lynch syndrome patients with EPCAM germline deletions. | ||
| 700 | 1 | |a Voigt, Anita Yvonne |e VerfasserIn |0 (DE-588)1075286182 |0 (DE-627)833124722 |0 (DE-576)443359717 |4 aut | |
| 700 | 1 | |a Schackert, Hans K. |e VerfasserIn |0 (DE-588)1105593142 |0 (DE-627)862721326 |0 (DE-576)169890007 |4 aut | |
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 700 | 1 | |a Knebel Doeberitz, Magnus von |e VerfasserIn |0 (DE-588)1022165291 |0 (DE-627)71693289X |0 (DE-576)364934239 |4 aut | |
| 700 | 1 | |a Bläker, Hendrik |d 1969- |e VerfasserIn |0 (DE-588)12093860X |0 (DE-627)08098150X |0 (DE-576)292457324 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 29(2011), 2, Seite 223-227 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Analysis of EPCAM protein expression in diagnostics of Lynch syndrome |
| 773 | 1 | 8 | |g volume:29 |g year:2011 |g number:2 |g pages:223-227 |g extent:5 |a Analysis of EPCAM protein expression in diagnostics of Lynch syndrome |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Kloor, Matthias, 1972 - |t Analysis of EPCAM protein expression in diagnostics of Lynch syndrome |d 2011 |w (DE-627)1632905663 |w (DE-576)366092243 |
| 856 | 4 | 0 | |u https://doi.org/10.1200/JCO.2010.32.0820 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://ascopubs.org/doi/10.1200/JCO.2010.32.0820 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220919 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 12093860X |a Bläker, Hendrik |m 12093860X:Bläker, Hendrik |d 910000 |d 912000 |e 910000PB12093860X |e 912000PB12093860X |k 0/910000/ |k 1/910000/912000/ |p 6 |y j | ||
| 998 | |g 1022165291 |a Knebel Doeberitz, Magnus von |m 1022165291:Knebel Doeberitz, Magnus von |d 910000 |d 912000 |e 910000PK1022165291 |e 912000PK1022165291 |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 998 | |g 124552803 |a Kloor, Matthias |m 124552803:Kloor, Matthias |d 910000 |d 912000 |e 910000PK124552803 |e 912000PK124552803 |k 0/910000/ |k 1/910000/912000/ |p 1 |x j | ||
| 999 | |a KXP-PPN181693030X |e 418995795X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Kloor","display":"Kloor, Matthias","given":"Matthias","role":"aut"},{"display":"Voigt, Anita Yvonne","given":"Anita Yvonne","family":"Voigt","role":"aut"},{"role":"aut","family":"Schackert","given":"Hans K.","display":"Schackert, Hans K."},{"role":"aut","family":"Schirmacher","display":"Schirmacher, Peter","given":"Peter"},{"role":"aut","family":"Knebel Doeberitz","given":"Magnus von","display":"Knebel Doeberitz, Magnus von"},{"role":"aut","display":"Bläker, Hendrik","given":"Hendrik","family":"Bläker"}],"recId":"181693030X","origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"name":{"displayForm":["Matthias Kloor, Anita Y. Voigt, Hans K. Schackert, Peter Schirmacher, Magnus von Knebel Doeberitz, and Hendrik Bläker"]},"language":["eng"],"title":[{"title_sort":"Analysis of EPCAM protein expression in diagnostics of Lynch syndrome","title":"Analysis of EPCAM protein expression in diagnostics of Lynch syndrome"}],"physDesc":[{"extent":"5 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["181693030X"],"doi":["10.1200/JCO.2010.32.0820"]},"relHost":[{"recId":"313116962","disp":"Analysis of EPCAM protein expression in diagnostics of Lynch syndromeJournal of clinical oncology","language":["eng"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1983 -"],"corporate":[{"role":"isb","display":"American Society of Clinical Oncology"}],"origin":[{"dateIssuedDisp":"1983-","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","dateIssuedKey":"1983"}],"title":[{"title":"Journal of clinical oncology","title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2011","pages":"223-227","volume":"29","text":"29(2011), 2, Seite 223-227","extent":"5","issue":"2"},"id":{"eki":["313116962"],"issn":["1527-7755"],"zdb":["2005181-5"]},"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"]}],"note":["Published online ahead of print at www.jco.org on November 29, 2010","Gesehen am 19.09.2022"]} | ||
| SRT | |a KLOORMATTHANALYSISOF2011 | ||